|
Sir Andrew Dillon, (born 9 May 1954) is the chief executive of the National Institute for Health and Care Excellence (NICE). He was general manager of the Royal Free Hospital and chief executive of St George's Healthcare NHS Trust. He joined NICE as its founding chief executive in 1999. In September 2013 he wrote an open letter to The Times in which he said companies should be sure that all expenses spent on research were necessary in order justify the high prices demanded for new products assessed by health technology assessment (HTA) bodies such as NICE. “If it really does cost £1.2bn to develop a new drug, the question the pharmaceutical industry must be able to answer is this: are you absolutely confident that it needs to?” He was said by the Health Service Journal to be the 34th most powerful person in the English NHS in December 2013. and among The 25 most influential people in biopharma today. ==Early life== Dillon was born in Sale, Cheshire. He attended St Ambrose College, Hale Barns, Cheshire, then North Cheshire College of Further Education and finally Manchester University. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Andrew Dillon」の詳細全文を読む スポンサード リンク
|